Rizatriptan
It is a 5HT1 agonist.Treatment of acute migraine attacks.
Adults:10mg as soon as possible after onset of migraine; may be repeated after 2 hours if migraine recurs; patients not responding should not take second dose for same attack. Maximum 20mg in 24 hours. Children and upto 18 years : not recommended.
Previous cerebrovascular accident or transient ischaemic attack, peripheral vascular disease.
Renal impairment. Not to be taken until 24 hours of stopping an ergotamine-like preparation.
Palpitation, dry mouth, diarrhoea, dyspepsia, headache, tremor, confusion, muscle weakness, drowsiness, tachycardia, pharyngeal, nervousness, vertigo.
Antibacterials, antidepressants, beta blockers, ergotamine.
Brand Name | Manufactured by |
---|---|
RIZACT | CIPLA |
RIZORA | INTAS PHARMACEUTICALS LTD. |
Brand Name | Manufactured by |
---|---|
RZT MD | ANT PHARMACEUTICALS PRIVATE LIMITED |